vitamin D2 ergocalciferol chelated
Selected indexed studies
- [Cutaneous calciphylaxis]. (Hautarzt, 2010) [PMID:21103856]
- New therapies: calcimimetics, phosphate binders and vitamin D receptor activators. (Pediatr Nephrol, 2010) [PMID:20151157]
- Experimental band keratopathy. (Arch Ophthalmol, 1969) [PMID:4974509]
_Worker-drafted node — pending editorial review._
Connections
vitamin D2 ergocalciferol chelated protects against
vitamin D2 ergocalciferol chelated helps
Sources
- [Cutaneous calciphylaxis]. (2010) pubmed
- New therapies: calcimimetics, phosphate binders and vitamin D receptor activators. (2010) pubmed
- Experimental band keratopathy. (1969) pubmed
- Secondary Hyperparathyroidism in a Patient with CKD. (2020) pubmed
- Neurotropic calciphylaxis. (1963) pubmed
- Efficacy of a non-hypercalcemic vitamin-D2 derived anti-cancer agent (MT19c) and inhibition of fatty acid synthesis in an ovarian cancer xenograft model. (2012) pubmed
- [Clinical advances in vascular calcification]. (2008) pubmed
- Inhibitory effect of vitamin D2 on adenosine-triphosphatase activity. (1966) pubmed
- Interventions for metabolic bone disease in children with chronic kidney disease. (2015) pubmed
- Prevention and treatment of secondary hyperparathyroidism: still a challenge for the nephrologist? (2003) pubmed